NCT01497314

Brief Summary

The purpose of this study is to show that a low lactose milk-based infant formula supports normal growth in healthy term infants.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2011

Geographic Reach
1 country

6 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2011

Completed
14 days until next milestone

First Submitted

Initial submission to the registry

December 15, 2011

Completed
7 days until next milestone

First Posted

Study publicly available on registry

December 22, 2011

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2013

Completed
Last Updated

May 15, 2013

Status Verified

May 1, 2013

Enrollment Period

1.2 years

First QC Date

December 15, 2011

Last Update Submit

May 14, 2013

Conditions

Keywords

healthy term infantsgrowthinfant formula

Outcome Measures

Primary Outcomes (1)

  • Weight

    16 weeks

Secondary Outcomes (3)

  • Length gain

    16 weeks

  • Occipital Head Circumference

    16 weeks

  • Acceptability and Tolerability

    16 weeks

Study Arms (1)

Low Lactose Infant Formula

OTHER
Other: Low Lactose Infant Formula

Interventions

Low Lactose Infant Formula

Low Lactose Infant Formula

Eligibility Criteria

AgeUp to 14 Days
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • healthy term infants
  • birth weight 2500 - 4500 g
  • singleton birth
  • weeks gestation

You may not qualify if:

  • clinically significant abnormal findings (as determined by the investigator) on the physical examination or medical history
  • receiving medications other than vitamins

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (6)

Accelovance Melbourne Site

Melbourne, Florida, 23935, United States

Location

ACC Pediatric Research

Haughton, Louisiana, 71037, United States

Location

Center for Pharmaceutical Research

Kansas City, Missouri, 64114, United States

Location

Research Across America

Dallas, Texas, 75234, United States

Location

Jean Brown Research

Murray, Utah, 84107, United States

Location

PI-Coor Research

Burke, Virginia, 22015-1635, United States

Location

Study Officials

  • Cynthia M Barber, PhD

    Perrigo Nutritionals

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 15, 2011

First Posted

December 22, 2011

Study Start

December 1, 2011

Primary Completion

March 1, 2013

Study Completion

March 1, 2013

Last Updated

May 15, 2013

Record last verified: 2013-05

Locations